Robert B M Landewé
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
2022/11/10 by Josef S Smolen, Robert B M Landewé, Robert Landewé +63 · 42 citations
Medicine · Immunology and Microbiology · #Rheumatoid Arthritis Research and Therapies #Biosimilars and Bioanalytical Methods #Hemophilia Treatment and Research
- Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients
2019/03/16 by Frances Humby, Myles Lewis, Nandhini Ramamoorthi +32 · 33 citations
Medicine · #Rheumatoid Arthritis Research and Therapies #Spondyloarthritis Studies and Treatments #Musculoskeletal synovial abnormalities and treatments
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
2020/01/22 by Josef S Smolen, Robert B M Landewé, Robert Landewé +62 · 31 citations
Medicine · Immunology and Microbiology · #Rheumatoid Arthritis Research and Therapies #Biosimilars and Bioanalytical Methods #Systemic Lupus Erythematosus Research
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
2020/06/01 by Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer +37 · 29 citations
Medicine · Immunology and Microbiology · #Spondyloarthritis Studies and Treatments #Rheumatoid Arthritis Research and Therapies #Psoriasis: Treatment and Pathogenesis
- ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
2022/10/21 by Sofía Ramiro, Sofia Ramiro, Elena Nikiphorou +46 · 30 citations
Medicine · #Spondyloarthritis Studies and Treatments #Rheumatoid Arthritis Research and Therapies #Scoliosis diagnosis and treatment